New York University Langone Medical Center
New York, New York, United States
Medical school in New York City, New York
550 1st Ave., New York, NY 10016
About New York University Langone Medical Center
NYU Grossman School of Medicine is a medical school of New York University, a private research university in New York City. It was founded in 1841 and is one of two medical schools of the university, with the other being the Long Island School of Medicine.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
NYU Langone Health
80
National Institute of Allergy and Infectious Diseases (NIAID)
30
National Cancer Institute (NCI)
16
Boston Scientific Corporation
10
Children's Oncology Group
10
Hoffmann-La Roche
10
Janssen Research & Development, LLC
8
National Institute on Aging (NIA)
7
Therapeutic Advances in Childhood Leukemia Consortium
7
University of Alabama at Birmingham
7
Eli Lilly and Company
5
Clinical Trials at New York University Langone Medical Center
During the past decade, New York University Langone Medical Center conducted 175 clinical trials. In the 10-year time frame, 175 clinical trials started and 128 clinical trials were completed, i.e. on
average, 73.1% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 59 clinical trials were completed. i.e. 122.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3
1995-11-01
Completed
2,100
A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS
1994-09-01
Completed
290
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
1994-12-01
Completed
90
A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
1993-05-01
Completed
750
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "New York University Langone Medical Center" #1 sponsor was "NYU Langone Health" with 80 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 30 trials
sponsored, "National Cancer Institute (NCI)" with 16 trials sponsored, "Boston Scientific Corporation" with 10 trials sponsored and "Children's Oncology Group"
with 10 trials sponsored. Other sponsors include 277 different institutions and
companies that sponsored additional 184 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "New York University Langone Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator, "NYU Langone Health" with 14 trials as a collaborator, "National Institute on Aging (NIA)" with 8 trials as a collaborator and "Bristol-Myers Squibb" with 6 trials as a collaborator. Other collaborators include 341 different institutions and companies that were
collaborators in the rest 238 trials.
Clinical Trials Conditions at New York University Langone Medical Center
According to Clinical.Site data, the most researched conditions in "New York University Langone Medical Center" are
"HIV Infections" (42 trials), "Hypertension" (12 trials), "Alzheimer Disease" (10 trials), "Alzheimer's Disease" (8 trials) and "Breast Cancer" (7 trials). Many other conditions were trialed in "New York University Langone Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at New York University Langone Medical Center
Most popular intervention types in "New York University Langone Medical Center" are "Drug" (275 trials), "Device" (70 trials), "Other" (53 trials), "Biological" (35 trials) and "Procedure" (28 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (46 trials), "laboratory biomarker analysis" (11 trials), "Zidovudine" (10 trials), "leucovorin calcium" (10 trials) and "Carboplatin" (8 trials). Other intervention names were less common.
Clinical Trials Genders at New York University Langone Medical Center
The vast majority of trials in "New York University Langone Medical Center" are
395 trials for "All" genders, 23 trials for "Female" genders and 10 trials for "Male" genders.
Clinical Trials Status at New York University Langone Medical Center
Currently, there are 98 active trials in "New York University Langone Medical Center".
1 are not yet recruiting,
49 are recruiting,
42 are Active, not recruiting,
and 6 are Enrolling by invitation.
In total, there were 264 completed trials in New York University Langone Medical Center,
1 suspended trials,
and 47 terminated clinical trials to date.
Out of the total trials that were conducted in New York University Langone Medical Center, 61 "Phase 1"
clinical trials were conducted, 124 "Phase 2" clinical
trials and 102 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 21 trials, and there were
also 93 trials that are defined as “Not Applicable".